Loading
Latest filing published 30 Sept 2019 for Algernon Pharmaceuticals Inc., €11k.
Kulwant Malhi is a declared insider of Algernon Pharmaceuticals Inc., with filings sourced from SEDI. Between 8 February 2019 and 27 September 2019, the trades on record add up to 2 filings.
The open-market record is one-sided, with 2 purchases worth €17k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The newest entry dates from 30 September 2019: an open-market purchase of €11k, in Algernon Pharmaceuticals Inc. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations